UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2024-06, Vol.59 (6), p.751-758

2024

Volltextzugriff (PDF)

Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience

Bone marrow transplantation (Basingstoke), 2024-08, Vol.59 (8), p.1161-1168

2024

Volltextzugriff (PDF)

Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series

Bone marrow transplantation (Basingstoke), 2022-07, Vol.57 (7), p.1133-1141

2022

Volltextzugriff (PDF)

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group

Bone marrow transplantation (Basingstoke), 2021-09, Vol.56 (9), p.2272

2021

Volltextzugriff (PDF)

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

Bone marrow transplantation (Basingstoke), 2022-06, Vol.57 (6), p.949-958

2022

Volltextzugriff (PDF)

Psychological stress symptoms before and after autologous bone marrow transplantation in patients with solid tumors

Bone marrow transplantation (Basingstoke), 1996-05, Vol.17 (5), p.843-847

1996

Volltextzugriff (PDF)

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)

Bone marrow transplantation (Basingstoke), 2021-09, Vol.56 (9), p.2272-2275

2021

Volltextzugriff (PDF)

Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation

Bone marrow transplantation (Basingstoke), 2002-12, Vol.30 (11), p.733-740

2002

Volltextzugriff (PDF)

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.580-587

2017

Volltextzugriff (PDF)

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies

Bone marrow transplantation (Basingstoke), 2008-02, Vol.41 (3), p.229-237

2008

Volltextzugriff (PDF)

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2006-09, Vol.38 (6), p.445-451

2006

Volltextzugriff (PDF)

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.961-966

2016

Volltextzugriff (PDF)

Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide

Bone marrow transplantation (Basingstoke), 2006-10, Vol.38 (8), p.547-553

2006

Volltextzugriff (PDF)

Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease

Bone marrow transplantation (Basingstoke), 2007-07, Vol.40 (1), p.79-82

2007

Volltextzugriff (PDF)

Early complications following haematopoietic SCT in children

Bone marrow transplantation (Basingstoke), 2008-06, Vol.41 (S2), p.S39-S42

2008

Volltextzugriff (PDF)

Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.622-634

2021

Volltextzugriff (PDF)

Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2004-05, Vol.33 (9), p.955-962

2004

Volltextzugriff (PDF)

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

Bone marrow transplantation (Basingstoke), 2024-05, Vol.59 (5), p.670-679

2024

Volltextzugriff (PDF)

Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity

Bone marrow transplantation (Basingstoke), 2005-05, Vol.35 (9), p.915-920

2005

Volltextzugriff (PDF)

Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors

Bone marrow transplantation (Basingstoke), 2004-01, Vol.33 (2), p.171-176

2004

Volltextzugriff (PDF)

Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1

Bone marrow transplantation (Basingstoke), 2024-06, Vol.59 (6), p.813-823

2024

Volltextzugriff (PDF)

Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis

Bone marrow transplantation (Basingstoke), 2023-02, Vol.58 (2), p.175-185

2023

Volltextzugriff (PDF)

Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1504-1511

2017

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

Zeitschrift / SerieBone Marrow Transplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(69)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(69)

Sprache

Englisch
(69)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
(69)
Nature Journals Online
(69)
Journals@Ovid Ovid Full Text
(61)
MEDLINE
(34)
IngentaConnect
(13)
Publisher website
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The International Journal Of Developmental Biology
(1)

Menü

Weitere Dienste

Einstellungen

Rituximab added to conditioning regimen significantly improves erythroid engraftment in major incompatible ABO-group hematopoietic stem cell transplantation

Safety and efficacy of narsoplimab in pediatric and adult patients with transplant-associated thrombotic microangiopathy: a real-world experience

Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group

Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

Psychological stress symptoms before and after autologous bone marrow transplantation in patients with solid tumors

Changes in Stem Cell Transplant activity and procedures during SARS-CoV2 pandemic in Italy: an Italian Bone Marrow Transplant Group (GITMO) nationwide analysis (TransCOVID-19 Survey)

Differential effects of G-CSF mobilisation on dendritic cell subsets in normal allogeneic donors and patients undergoing autologous transplantation

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies

Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease

Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS

Stem cell transplantation in children with infantile osteopetrosis is associated with a high incidence of VOD, which could be prevented with defibrotide

Prophylactic defibrotide in allogeneic stem cell transplantation: minimal morbidity and zero mortality from veno-occlusive disease

Early complications following haematopoietic SCT in children

Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation

Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison

Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity

Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors

Reduced toxicity (FluBu3) versus myeloablative (BuCy) conditioning in acute myeloid leukemia patients who received first allogeneic hematopoietic stem cell transplantation in measurable residual disease-negative CR1

Myeloablative conditioning regimens in adult patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation in complete remission: a systematic review and network meta-analysis

Conditioning regimens for allogeneic hematopoietic stem cell transplants in acute myeloid leukemia

Aktive Filter

Suchergebnisse filtern